| NASDAQ (usa) |   | 6715.56 | -12.11 | -0.18% | 
| FTSE 100 (london) |  | 7487.96 | -5.12 | -0.07% | 
| DAX (german) |   | 13465.51 | 235.94 | 1.78% | 
| NIKKEI 225 (japan) |   | 22420.08 | 408.47 | 1.86% | 
| Hang - Seng (hong kong) |   | 28594.06 | 348.52 | 1.23% | 
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |   | 3391.61 | 17.53 | 0.52% | 
| KOSPI (korea) |   | 2556.47 | 33.04 | 1.31% | 
| All Ordinaries (australia) |   | 6005.30 | 28.90 | 0.48% | 
| BOVESPA (brazil) |   | 74092.76 | -215.73 | -0.29% | 
2cureX AB (ST: 2CUREX)
                                    	2CUREX Technical Analysis
                                    
                                    
    4
    
    
    
    
									| As on 30th Oct 2025 2CUREX STOCK Price closed @ 1.08 and we RECOMMEND Buy for LONG-TERM with Stoploss of 0.47 & Strong Buy for SHORT-TERM with Stoploss of 0.46 we also expect STOCK to react on Following IMPORTANT LEVELS. | 
2CUREXSTOCK Price
| Open | 1.06 | Change | Price | % | 
| High | 1.09 | 1 Day | 0.01 | 0.93 | 
| Low | 1.06 | 1 Week | -0.45 | -29.41 | 
| Close | 1.08 | 1 Month | -1.01 | -48.33 | 
| Volume | 33365 | 1 Year | 0.74 | 217.65 | 
| 52 Week High 5.48 | 52 Week Low 0.26 | ||||
    ST Sweden Most Active Stocks
                    | ENERS | 0.00 | % | 
| LIPI | 0.22 | -4.35% | 
| GABA | 0.05 | 66.67% | 
| GABA | 0.05 | 66.67% | 
| LUNE | 21.97 | 6.65% | 
| POLY | 0.04 | 0.00% | 
| TELIA | 37.36 | 1.77% | 
| ADDV-B | 1.07 | 5.94% | 
| INTRUM | 43.18 | -15.57% | 
| EURA | 0.01 | 0.00% | 
ST Sweden Top Gainers Stocks
                    
                ST Sweden Top Losers Stocks
                    
                | 2CUREX Daily Charts | 2CUREX Intraday Charts | Whats New @ Bazaartrend | 2CUREX Free Analysis | 
|  | 
2CUREX Important Levels Intraday
                                    | RESISTANCE | 1.14 | 
| RESISTANCE | 1.12 | 
| RESISTANCE | 1.11 | 
| RESISTANCE | 1.10 | 
| SUPPORT | 1.06 | 
| SUPPORT | 1.05 | 
| SUPPORT | 1.04 | 
| SUPPORT | 1.02 | 
2CUREX Forecast  October 2025
                                    | 4th UP Forecast | 2.02 | 
| 3rd UP Forecast | 1.72 | 
| 2nd UP Forecast | 1.53 | 
| 1st UP Forecast | 1.35 | 
| 1st DOWN Forecast | 0.81 | 
| 2nd DOWN Forecast | 0.63 | 
| 3rd DOWN Forecast | 0.44 | 
| 4th DOWN Forecast | 0.14 | 
     2CUREX Weekly Forecast
                                    
                                    
                                | 4th UP Forecast | 1.41 | 
| 3rd UP Forecast | 1.30 | 
| 2nd UP Forecast | 1.24 | 
| 1st UP Forecast | 1.17 | 
| 1st DOWN Forecast | 0.99 | 
| 2nd DOWN Forecast | 0.92 | 
| 3rd DOWN Forecast | 0.86 | 
| 4th DOWN Forecast | 0.75 | 
2CUREX Forecast2025
                                    | 4th UP Forecast | 11.22 | 
| 3rd UP Forecast | 7.97 | 
| 2nd UP Forecast | 5.96 | 
| 1st UP Forecast | 3.95 | 
| 1st DOWN Forecast | -1.79 | 
| 2nd DOWN Forecast | -3.8 | 
| 3rd DOWN Forecast | -5.81 | 
| 4th DOWN Forecast | -9.06 | 
                                        2cureX AB ( ST Sweden Symbol : 2CUREX ) 
Sector : Healthcare And Other Stocks in Same Sector
                                    
                                    
                                Sector : Healthcare And Other Stocks in Same Sector
2CUREX Other Details
                    | Segment | EQ | |
| Market Capital | 265881744.00 | |
| Sector | Healthcare | |
| Industry | Biotechnology | |
| Offical website | > echo $website ; ?> | |
2CUREX Address
                                 |  | ||
                                        2CUREX Latest News
                                    
                                    
                                    2CUREX Business Profile
   
	 2cureX AB (publ) operates as a medtech company in Europe. Its principal product is IndiTreat test that allows the physician to identify a medical treatment that is effective for a particular cancer patient. IndiTreat establishes thousands of 3D micro-tumors that are similar to the patient's tumor and identifies the treatment that kills the patient's tumor. The company is also conducting various clinical programs for IndiTreat for colorectal, ovarian, and pancreatic cancers. 2cureX AB has clinical partnerships with Skåne University Hospital in Sweden; and University Medical Center Hamburg-Eppendorf. The company was incorporated in 2006 and is based in Copenhagen, Denmark. Address: Fruebjergvej 3, Copenhagen, Denmark, 2100 
	
            
            © 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
 
	   Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service

